-
NMPA Issued the Notice on Enabling the New Version of the Drug Production License and other Certificates
2019-08-07
To standardize the formats and renewal of the drug administrative licenses, on August 7, 2019, NMPA issued the Notice on Enabling the New Version of the Drug Production License and other Certificates,and notified the relevant matters as follows.
-
NMPA, Ministry of Public Security, National Health Commission issued the Announcement on the Inclusion of Oxycodone-Containing Compound Preparations in the Management of Psychotropic Substances
2019-08-06
NMPA,the Ministry of Public Security, and the National Health Commission decided to include oxycodone containing compound preparations in the management of psychotropic substances.
-
NMPA Issued the Announcement on Issues Pertaining to the Implementation of Drug Standards in the Consistency Evaluation of the Quality and Efficacy of Generic Drugs
2019-08-02
NMPA issued the Announcement on Issues Pertaining to the Implementation of Drug Standards in the Consistency Evaluation of the Quality and Efficacy of Generic Drugs.
-
NMPA Issued the Notice on Expanding the Pilot of the Medical Device Registrant System
2019-08-01
NMPA issued the Notice on Expanding the Pilot of the Medical Device Registrant System (NMPA Department for Medical Device Registration [2019] No. 33.
-
NMPA Issued the Announcement on Cancellation of 16 Certification Items (Second Batch)
2019-07-24
NMPA issued on July 24, 2019 the Announcement on Cancellation of 16 Certification Items (Second Batch).
-
NMPA Issued the Announcement on the Requirements for Relevant Electronic Application Dossiers of Medical Devices
2019-07-19
NMPA issued the Announcement on the Requirements for Relevant Electronic Application Dossiers of Medical Devices,to regulate the submission of relevant dossiers.